Methasterone, widely known by its colloquial name Superdrol, is a synthetic anabolic compound derived from dihydrotestosterone (DHT) with a notably unconventional research history compared to most oral anabolic steroids. Unlike the majority of compounds in CSD’s oral range which carry decades of pharmaceutical or clinical documentation, Methasterone was originally synthesized in the 1950s but never developed for pharmaceutical use, instead surfacing in the early 2000s as a designer prohormone supplement before being scheduled as a controlled substance. F40 Biotech’s formulation delivers 15mg per tablet in a 50 count format, a precisely dosed presentation consistent with the concentrations most commonly referenced in contemporary anabolic research literature. Methasterone’s pharmacological profile is defined by an exceptionally high anabolic to androgenic ratio, estimated anabolic activity approximately four times that of Methyltestosterone with significantly reduced androgenic activity relative to its anabolic potency. As a DHT derived compound it does not aromatize, producing no estrogenic conversion regardless of dose. Methasterone is not 17 alpha alkylated in the traditional sense but carries a 2 alpha, 17 alpha dimethyl modification that confers oral bioavailability while producing a distinct hepatic metabolism pathway compared to standard alkylated oral compounds, a structural difference that has generated specific research interest in comparative oral bioavailability and hepatotoxicity studies across modified DHT derivatives. The 2 alpha methyl modification at the second carbon position is the structural feature that most distinguishes Methasterone from other DHT derived oral anabolic compounds in research. This modification significantly increases anabolic potency relative to the base DHT structure while the 17 alpha methyl group provides oral bioavailability, the combination producing one of the highest anabolic activity profiles among oral DHT derivatives documented in the research literature. Despite its relatively recent emergence as a research compound compared to mid 20th century anabolics, Methasterone has accumulated a growing body of literature examining its receptor binding characteristics and metabolic pathway given its unique dimethyl modification structure. F40 Biotech formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and F40 Biotech’s Methasterone meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior. Store in a cool, dry place away from direct light and heat. Intended for research purposes only. Commonly researched alongside liver support compounds and testosterone base compounds. Browse CSD’s full oral range and PCT compounds for complete protocol sourcing.